With demand for colonoscopy and IBD care climbing—and private equity accelerating practice acquisitions—gastroenterologists face a shifting medicolegal minefield. A new update in Clinical Gastroenterology and Hepatology highlights how Stark Law, Anti-Kickback rules, ASC investments, and PE-driven structures can quietly threaten physician autonomy and expose practices to costly penalties. The message is clear: growth opportunities in ancillaries, ASCs, and PE deals are real, but only if contracts and compliance structures are airtight.
Keep Reading
Add A Comment